Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat

Michael R. Hoane, Arlene A. Tan, Jeremy L. Pierce, Gail D. Anderson, Douglas C. Smith

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

This study examined the ability of nicotinamide (vitamin B3) to improve functional outcome in a dose-dependent manner following fluid percussion injury (FPI). Injured (duration of unconsciousness mean = 85.8 sec; apnea = 9.9 sec), rats were administered nicotinamide (500 or 50 mg/kg; ip) or saline at 15 min and 24 h. Serum analysis of nicotinamide concentrations were conducted 1 h following the last injection. Sensorimotor and cognitive tests were conducted for 35 days following FPI. Both the 500 and 50 mg/kg doses of nicotinamide significantly facilitated recovery on the vibrissae-forelimb placing test compared to saline treatment, which showed chronic impairments. Both treatments also significantly improved performance on the bilateral tactile adhesive removal test. On the cognitive tests, the 500 mg/kg dose, but not the 50 mg/kg dose, improved performance on a working memory task in the Morris water maze (MWM). However, acquisition of a reference memory task in the MWM was not improved. Serum analysis showed that the 500 mg/kg dose significantly raised nicotinamide concentrations by 30-fold and the 50 mg/kg dose by 3-fold compared to the saline administration. This study demonstrated that raising nicotinamide concentrations resulted in the reduction of the behavioral impairments following FPI. In fact, the 500 mg/kg dose prevented the occurrence of the behavioral deficits on the bilateral tactile removal and working memory tests. Both doses significantly reduced tissue loss and glial fibrillary acid protein (GFAP) expression in the cortex. The 500 mg/kg dose reduced GFAP expression in the hippocampus. This data suggests that nicotinamide has substantial preclinical efficacy for TBI, and there appears to be some differences in the ability of the doses to improve performance in the MWM.

Original languageEnglish (US)
Pages (from-to)1535-1548
Number of pages14
JournalJournal of Neurotrauma
Volume23
Issue number10
DOIs
StatePublished - Oct 1 2006
Externally publishedYes

Fingerprint

Percussion
Niacinamide
Wounds and Injuries
Aptitude
Glial Fibrillary Acidic Protein
Touch
Therapeutics
Short-Term Memory
Water
Vibrissae
Unconsciousness
Forelimb
Apnea
Serum
Adhesives
Hippocampus
Injections

Keywords

  • Behavior
  • GFAP
  • Neuroprotection
  • Recovery of function
  • TBI
  • Vitamin B

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat. / Hoane, Michael R.; Tan, Arlene A.; Pierce, Jeremy L.; Anderson, Gail D.; Smith, Douglas C.

In: Journal of Neurotrauma, Vol. 23, No. 10, 01.10.2006, p. 1535-1548.

Research output: Contribution to journalArticle

Hoane, Michael R. ; Tan, Arlene A. ; Pierce, Jeremy L. ; Anderson, Gail D. ; Smith, Douglas C. / Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat. In: Journal of Neurotrauma. 2006 ; Vol. 23, No. 10. pp. 1535-1548.
@article{bde52194c584435b9b288eef307d0372,
title = "Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat",
abstract = "This study examined the ability of nicotinamide (vitamin B3) to improve functional outcome in a dose-dependent manner following fluid percussion injury (FPI). Injured (duration of unconsciousness mean = 85.8 sec; apnea = 9.9 sec), rats were administered nicotinamide (500 or 50 mg/kg; ip) or saline at 15 min and 24 h. Serum analysis of nicotinamide concentrations were conducted 1 h following the last injection. Sensorimotor and cognitive tests were conducted for 35 days following FPI. Both the 500 and 50 mg/kg doses of nicotinamide significantly facilitated recovery on the vibrissae-forelimb placing test compared to saline treatment, which showed chronic impairments. Both treatments also significantly improved performance on the bilateral tactile adhesive removal test. On the cognitive tests, the 500 mg/kg dose, but not the 50 mg/kg dose, improved performance on a working memory task in the Morris water maze (MWM). However, acquisition of a reference memory task in the MWM was not improved. Serum analysis showed that the 500 mg/kg dose significantly raised nicotinamide concentrations by 30-fold and the 50 mg/kg dose by 3-fold compared to the saline administration. This study demonstrated that raising nicotinamide concentrations resulted in the reduction of the behavioral impairments following FPI. In fact, the 500 mg/kg dose prevented the occurrence of the behavioral deficits on the bilateral tactile removal and working memory tests. Both doses significantly reduced tissue loss and glial fibrillary acid protein (GFAP) expression in the cortex. The 500 mg/kg dose reduced GFAP expression in the hippocampus. This data suggests that nicotinamide has substantial preclinical efficacy for TBI, and there appears to be some differences in the ability of the doses to improve performance in the MWM.",
keywords = "Behavior, GFAP, Neuroprotection, Recovery of function, TBI, Vitamin B",
author = "Hoane, {Michael R.} and Tan, {Arlene A.} and Pierce, {Jeremy L.} and Anderson, {Gail D.} and Smith, {Douglas C.}",
year = "2006",
month = "10",
day = "1",
doi = "10.1089/neu.2006.23.1535",
language = "English (US)",
volume = "23",
pages = "1535--1548",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat

AU - Hoane, Michael R.

AU - Tan, Arlene A.

AU - Pierce, Jeremy L.

AU - Anderson, Gail D.

AU - Smith, Douglas C.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - This study examined the ability of nicotinamide (vitamin B3) to improve functional outcome in a dose-dependent manner following fluid percussion injury (FPI). Injured (duration of unconsciousness mean = 85.8 sec; apnea = 9.9 sec), rats were administered nicotinamide (500 or 50 mg/kg; ip) or saline at 15 min and 24 h. Serum analysis of nicotinamide concentrations were conducted 1 h following the last injection. Sensorimotor and cognitive tests were conducted for 35 days following FPI. Both the 500 and 50 mg/kg doses of nicotinamide significantly facilitated recovery on the vibrissae-forelimb placing test compared to saline treatment, which showed chronic impairments. Both treatments also significantly improved performance on the bilateral tactile adhesive removal test. On the cognitive tests, the 500 mg/kg dose, but not the 50 mg/kg dose, improved performance on a working memory task in the Morris water maze (MWM). However, acquisition of a reference memory task in the MWM was not improved. Serum analysis showed that the 500 mg/kg dose significantly raised nicotinamide concentrations by 30-fold and the 50 mg/kg dose by 3-fold compared to the saline administration. This study demonstrated that raising nicotinamide concentrations resulted in the reduction of the behavioral impairments following FPI. In fact, the 500 mg/kg dose prevented the occurrence of the behavioral deficits on the bilateral tactile removal and working memory tests. Both doses significantly reduced tissue loss and glial fibrillary acid protein (GFAP) expression in the cortex. The 500 mg/kg dose reduced GFAP expression in the hippocampus. This data suggests that nicotinamide has substantial preclinical efficacy for TBI, and there appears to be some differences in the ability of the doses to improve performance in the MWM.

AB - This study examined the ability of nicotinamide (vitamin B3) to improve functional outcome in a dose-dependent manner following fluid percussion injury (FPI). Injured (duration of unconsciousness mean = 85.8 sec; apnea = 9.9 sec), rats were administered nicotinamide (500 or 50 mg/kg; ip) or saline at 15 min and 24 h. Serum analysis of nicotinamide concentrations were conducted 1 h following the last injection. Sensorimotor and cognitive tests were conducted for 35 days following FPI. Both the 500 and 50 mg/kg doses of nicotinamide significantly facilitated recovery on the vibrissae-forelimb placing test compared to saline treatment, which showed chronic impairments. Both treatments also significantly improved performance on the bilateral tactile adhesive removal test. On the cognitive tests, the 500 mg/kg dose, but not the 50 mg/kg dose, improved performance on a working memory task in the Morris water maze (MWM). However, acquisition of a reference memory task in the MWM was not improved. Serum analysis showed that the 500 mg/kg dose significantly raised nicotinamide concentrations by 30-fold and the 50 mg/kg dose by 3-fold compared to the saline administration. This study demonstrated that raising nicotinamide concentrations resulted in the reduction of the behavioral impairments following FPI. In fact, the 500 mg/kg dose prevented the occurrence of the behavioral deficits on the bilateral tactile removal and working memory tests. Both doses significantly reduced tissue loss and glial fibrillary acid protein (GFAP) expression in the cortex. The 500 mg/kg dose reduced GFAP expression in the hippocampus. This data suggests that nicotinamide has substantial preclinical efficacy for TBI, and there appears to be some differences in the ability of the doses to improve performance in the MWM.

KW - Behavior

KW - GFAP

KW - Neuroprotection

KW - Recovery of function

KW - TBI

KW - Vitamin B

UR - http://www.scopus.com/inward/record.url?scp=33845230959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845230959&partnerID=8YFLogxK

U2 - 10.1089/neu.2006.23.1535

DO - 10.1089/neu.2006.23.1535

M3 - Article

VL - 23

SP - 1535

EP - 1548

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 10

ER -